Sublingual immunotherapy - Results from a multi-centre, randomised, double-blind, placebo-controlled study with a standardised birch and grass/rye pollen extract;Sublinguale immunotherapie - Ergebnisse einer randomisierten, doppelblinden, plazebokontrollierten multicenterstudie mit einem standardisierten birken- und gräser-/roggenpollenextrakt

Allergologie

Volumn 24, Issue 11, 2001, Pages 525-534

  Drachenberg, K J ^a   Pfeiffer, P ^a   Urban, E ^a  

^a Bencard Allergie GmbH   (Germany)

Author keywords

Asthma; Birch pollen; Conjunctivitis; Grass rye pollen; Rhinitis; Sublingual immunotherapy

Indexed keywords

ORALVAC; POLLEN ANTIGEN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ALLERGIC CONJUNCTIVITIS; ALLERGIC RHINITIS; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; GRASS POLLEN; HUMAN; IMMUNOTHERAPY; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PHARYNGITIS; PRICK TEST; RANDOMIZED CONTROLLED TRIAL; RHINOCONJUNCTIVITIS; SCHOOL CHILD; STOMATITIS;

EID: 0035196772     PISSN: 03445062     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Mechanisms of allergen-specific immunotherapy
2. Safety of sublingual-swallow immunotherapy in children and adults
3. Absorption and distribution kinetics of the major Parietaria judaica allergen (Parj 1) administered by noninjectable routes in healthy human beings
4. Sublingual-swallow immunotherapy (SLIT) in patients with asthma due to house-dust mites: A double-blind, placebo-controlled study
5. Allergen immunotherapy: Therapeutic vaccines for allergic diseases. WHO position paper
6. Clinical efficacy of sublingual-swallow immunotherapy: A double-blind, placebo-controlled trial of a standardized five-grass-pollen extract in rhinitis
7. Die allergische immuntherapie (Hyposensibilisierung), teil 2: Orale, sublinguale und nasale applikation
8. Housedust-mite sublingual-swallow immunotherapy (SLIT) in perennial rhinitis: A double-blind, placebo-controlled study
9. Double-blind placebo-controlled study of sublingual immunotherapy with house dust mite extract (D.pt.) in children
10. Immunotherapy with sublingual birch pollen extract. A short-term double-blind placebo study
11. Sublingual immunotherapy with a standardized grass pollen extract; a double-blind placebo-controlled study
12. Die spezifische immuntherapie (Hyposensibilisierung) mit allergenen. Positionspapier der deutschen gesellschaft für allergologie und klinische immunologie
13. Therapiestudien zur sublingualen immuntherapie mit allergenen - Eine aktuelle bestandsaufnahme
14. Double-blind placebo-controlled evaluation of sublingual-swallow immunotherapy with standardized Parietaria judaica extract in children with allergic rhinoconjunctivitis
15. Position paper (EAACI/ ESPACI) - Local immunotherapy
16. Positive ergebnisse einer ersten multizentrischen untersuchung - Spezifische immuntherapie sublingual applizierbar
17. Comparison of the efficacy of subcutaneous and sublingual immunotherapy in mite-sensitive patients with rhinitis and asthma - A placebo-controlled study
18. Clinical and immunologic effects of a rush sublingual immunotherapy to Parietaria species: A double-blind placebo-controlled trial
19. Randomised Controlled trial of local allergoid immunotherapy on allergic inflammation in mite-induced rhinoconjunctivitis
20. Sublingual immunotherapy: A double-blind, placebo-controlled trial with Parietaria judaica extract standardized in mass units in patients with rhinoconjunctivitis, asthma, or both
21. Sublingual versus injective immunotherapy in grass pollen allergic patients: A double blind (double dummy) study
22. Das WHO-Positionspapier zur spezifischen Immuntherapie
23. A double-blind, placebo-controlled trial by the sublingual route of immunotherapy with a standardized grass pollen extract
24. Efficacy of sublingual immunotherapy in patients with rhinitis and asthma due to house dust mite. A double-blind study
25. Consensus statement on the treatment of allergic rhinitis
26. Double-blind placebo-controlled evaluation of sublingual immunotherapy with standardized olive pollen extract in pediatric patients with allergic rhinoconjunctivitis and mild asthma due to olive pollen sensitization